S&N appoints Derma Sciences as wound dressing manufacturer:
This article was originally published in Clinica
Executive Summary
Princeton, New Jersey-based supplier of wound and skincare products Derma Sciences has secured a multi-year contract with UK group Smith & Nephew to manufacture an undisclosed line of wound dressings for worldwide sale. The deal is expected to generate revenues of $1m in the first year for Derma Sciences.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.